TRECYLVIS

Serial Number 99013355
686

Registration Progress

Application Filed
Jan 21, 2025
Under Examination
Approved for Publication
Jun 3, 2025
Published for Opposition
Jun 3, 2025
Registered

Basic Information

Serial Number
99013355
Filing Date
January 21, 2025
Published for Opposition
June 3, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jun 3, 2025
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Richard A. Friedman

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description
Jun 3, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 PUBO A PUBLISHED FOR OPPOSITION
May 28, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 3, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 3, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 3, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2025 DOCK D ASSIGNED TO EXAMINER
Feb 13, 2025 GNRT F NON-FINAL ACTION E-MAILED
Feb 13, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 13, 2025 CNRT R NON-FINAL ACTION WRITTEN
Jan 21, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
Jan 21, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 21, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Classification

International Classes
005